FDA warns against advertising unapproved products, urges media to enforce compliance

The Food and Drugs Authority (FDA) in the Ashanti Region has cautioned that no product should be advertised without prior approval, calling on the media to help ensure compliance.

Speaking at a media training workshop in Kumasi, Ashanti Regional Director Nathaniel Nana Nkrumah emphasized that products must be registered before advertising, with the FDA approving all wording and claims. He referenced Section 100(1) on food, Section 114(1) on cosmetics and household chemicals, and Section 148 of the Food and Drugs Act, which prohibits deceptive advertising.

Mr. Nkrumah warned that advertisements must reflect the specific purpose for which a product was registered. He cautioned against exaggerated claims, unfair comparisons, and “freestyle” promotions. FDA registration is valid for one to two years and is essential for maintaining fairness in the marketplace.

He highlighted that some products are banned from advertising, including tobacco, infant formula, prescription-only medicines for conditions such as hypertension, diabetes, and cancer, homeopathic medicines, and products linked to male sexual enhancement. Advertisements must not target children, pregnant or lactating mothers, or claim to treat diseases like HIV, Hepatitis B, epilepsy, and leprosy.

Regarding alcohol, Mr. Nkrumah clarified that no product has been approved as an aphrodisiac; all are registered strictly as beverages. He warned against misleading claims of “male vitality” and stated that adverts must not promote excessive drinking or link alcohol to success or sexual performance. Such adverts must carry health warnings and are prohibited from airing between 6:00 a.m. and 8:00 p.m.

Touching on herbal medicines, the FDA noted that health professionals and celebrities are prohibited from endorsing products. No advertisement should claim 100% efficacy or absence of side effects, and promotions involving gifts or refunds are not allowed.

All adverts must include safety warnings and encourage the reporting of side effects through the FDA Med Safety App.